Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Golden Throat Holdings Group Co's EV-to-FCF or its related term are showing as below:
HKSE:06896'
s EV-to-FCF Range Over the Past 10 Years
Min: -86.6 Med: 5.96 Max: 361.38
Current: 14.38
During the past 12 years, the highest EV-to-FCF of Golden Throat Holdings Group Co was 361.38. The lowest was -86.60. And the median was 5.96.
HKSE:06896's EV-to-FCF is ranked better than 61.9% of 567
companies
in the Drug Manufacturers industry
Industry Median: 20.01
vs HKSE:06896: 14.38
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Golden Throat Holdings Group Co (HKSE:06896) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Golden Throat Holdings Group Co's PE Ratio (TTM) for today is calculated as:
Golden Throat Holdings Group Co's share price for today is HK$2.275.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Golden Throat Holdings Group Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.324.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Golden Throat Holdings Group Co EV-to-FCF Related Terms
Golden Throat Holdings Group Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Golden Throat Holdings Group Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Golden Throat Holdings Group Co EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Golden Throat Holdings Group Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Golden Throat Holdings Group Co's EV-to-FCF falls into.
Golden Throat Holdings Group Co's current Enterprise Value is HK$1,238 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Golden Throat Holdings Group Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$86 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Golden Throat Holdings Group Co (HKSE:06896) has a EV-to-FCF of 14.38 as of Sep. 04, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Golden Throat Holdings Group Co and its competitors. This is 141% above median its historical median of 5.96. According to the industry distribution chart, Golden Throat Holdings Group Co ranks #216 out of 567 companies in the Drug Manufacturers industry, placing it in the top 38.1%.
Is Golden Throat Holdings Group Co's EV-to-FCF too high?
Golden Throat Holdings Group Co's current EV-to-FCF of 14.38 is 141% above median its 10-year median of 5.96. The Drug Manufacturers industry median EV-to-FCF is 20.01. Golden Throat Holdings Group Co's value of 14.38 is 28.1% below this industry median. Based on the distribution chart, Golden Throat Holdings Group Co ranks #216 out of 567 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Golden Throat Holdings Group Co has a GF Score™ of 83/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Golden Throat Holdings Group Co's EV-to-FCF compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Golden Throat Holdings Group Co ranks #216 out of 567 companies for EV-to-FCF. This puts Golden Throat Holdings Group Co in the upper half of its industry. The industry median EV-to-FCF is 20.01. Golden Throat Holdings Group Co's value of 14.38 is 28.1% below this benchmark. While the company's 10-year median is 5.96 vs. the industry median of 20.01, Golden Throat Holdings Group Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 20.01, based on 567 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Golden Throat Holdings Group Co's current EV-to-FCF of 14.38 is 28.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Golden Throat Holdings Group Co and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 20.01 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Golden Throat Holdings Group Co's current EV-to-FCF is 14.38, which is 141% above median its own 10-year median of 5.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Golden Throat Holdings Group Co stock overvalued right now?
Based on GuruFocus' analysis, Golden Throat Holdings Group Co (HKSE:06896) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$2.98, compared to a current price of HK$2.28 — trading 23.7% below its estimated fair value. The current EV-to-FCF is 14.38, which is 141% above median its 10-year median of 5.96 and 28.1% below the Drug Manufacturers industry median of 20.01. Golden Throat Holdings Group Co's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Golden Throat Holdings Group Co (HKSE:06896), the current EV-to-FCF is 14.38 as of Sep. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Golden Throat Holdings Group Co (HKSE:06896) Overvalued in 2026?
Based on GuruFocus' analysis, Golden Throat Holdings Group Co stock appears to be undervalued.
The current stock price of HK$2.28 is trading 23.7% below its estimated GF Value™ of HK$2.98.
GuruFocus considers Golden Throat Holdings Group Co to be Modestly Undervalued.
Key valuation signals for HKSE:06896:
EV-to-FCF: 14.38 (141% above median its 10-year median of 5.96)
GF Value™: HK$2.98 vs. price of HK$2.28 (23.7% below fair value)
Industry Position: 28.1% below the Drug Manufacturers median (#216 of 567)
No single metric tells the full story. See the HKSE:06896 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Golden Throat Holdings Group Co Ltd is an investment holding company. Through its subsidiaries, the company is engaged in the manufacture and sale of pharmaceuticals, healthcare food and other products. The compqny manufactures and sells lozenges and other pharmaceutical and food products. The key products of the group that derives revenue for the group are Golden Throat Lozenges (OTC), Golden Throat Lozenge Series products and other products. The group derives majority of its revenue from Mainland China.
83GF Score
Get the complete analysis for HKSE:06896
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:06896 has been successfully added to your 
